Jefferies Assumes, Upgrades Immunogen Inc. (IMGN) to Buy
Tweet Send to a Friend
Jefferies upgraded Immunogen Inc. (NASDAQ: IMGN) from Hold to Buy with a price target of $16.00 (from $8.00) in assumed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE